Asuragen – QuantideX ESR1 exoMutation Kit

ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain trigger constant activation of the receptor, leading to excessive downstream signalling.

Asuragen – AmplideX Nanopore Carrier Plus

Introducing the Asuragen AmplideX® Nanopore Carrier Plus Kit* – a revolutionary solution for carrier screening for challenging hard-to-read genes, leveraging long-read sequencing technology to provide unparalleled insights into genetic conditions. Expanded prenatal screening protocols traditionally require multiple methods to ensure full coverage of genes of interest.

Asuragen – QuantideX BCR-ABL

Asuragen’s Precision Oncology Solutions. Revolutionising Precision Oncology with QuantideX®: Where Sensitivity Meets Scalability

Asuragen’s AmplideX® PCR/CE CFTR Kit – Quality over Quantity

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. Cystic fibrosis (CF) is a life-limiting, autosomal recessive disease caused by the presence of pathogenic alterations in the CFTR gene.

Are you using Asuragen’s AmplideX FMR1 kit?

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. How is your lab performing FMR1 gene testing?

AmplideX Trio for Reproductive Genetic Carrier Screening

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. With the AmplideX Trio, you can use one shared workflow to analyze CFTR, SMN1/2, and FMR1. This saves your lab tech time, simplifies training, and reduces consumables used.